Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan Pentz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|August 28, 2021
The NGF Metabolic Pathway: New Opportunities for Biomarker Research and Drug Target Discovery : NGF Pathway Biomarkers and Drug TargetsRowan Pentz, M Florencia Iulita
Frontiers in Neuroscience|February 28, 2019
The Brain NGF Metabolic Pathway in Health and in Alzheimer's PathologyA Claudio Cuello, Rowan Pentz, Hélène Hall
Plos One|September 7, 2012
Stressor-like effects of c-Jun N-terminal kinase (JNK) inhibitionMelanie Clarke, Rowan Pentz, Jessica Bobyn, et al.
Frontiers in Neurology|November 11, 2024
Mean global field power is reduced in infantile epileptic spasms syndrome after response to vigabatrinArjun Nair, Joycelyne Ewusie, Rowan Pentz, et al.
Molecular Psychiatry|June 4, 2020
The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers diseaseRowan Pentz, M Florencia Iulita, Adriana Ducatenzeiler, et al.
Seizure|March 22, 2025
Biallelic SCN1A variants with divergent epilepsy phenotypesRowan Pentz, Rebecca Hough, Chumei Li, et al.
Journal of Neurochemistry|August 3, 2022
Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesisChiara Orciani, Hélène Hall, Rowan Pentz, et al.
Neurobiology of Disease|November 1, 2020
A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathologyRowan Pentz, M Florencia Iulita, Maya Mikutra-Cencora, et al.
Neuropharmacology|April 24, 2016
Ketamine modulates hippocampal neurogenesis and pro-inflammatory cytokines but not stressor induced neurochemical changesMelanie Clarke, Sara Razmjou, Natalie Prowse, et al.
Neuropsychiatric Disease and Treatment|September 24, 2016
The interactive effects of ketamine and magnesium upon depressive-like pathologySara Razmjou, Darcy Litteljohn, Chris Rudyk, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|August 28, 2021
The NGF Metabolic Pathway: New Opportunities for Biomarker Research and Drug Target Discovery : NGF Pathway Biomarkers and Drug TargetsRowan Pentz, M Florencia Iulita
Frontiers in Neuroscience|February 28, 2019
The Brain NGF Metabolic Pathway in Health and in Alzheimer's PathologyA Claudio Cuello, Rowan Pentz, Hélène Hall
Plos One|September 7, 2012
Stressor-like effects of c-Jun N-terminal kinase (JNK) inhibitionMelanie Clarke, Rowan Pentz, Jessica Bobyn, et al.
Frontiers in Neurology|November 11, 2024
Mean global field power is reduced in infantile epileptic spasms syndrome after response to vigabatrinArjun Nair, Joycelyne Ewusie, Rowan Pentz, et al.
Molecular Psychiatry|June 4, 2020
The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers diseaseRowan Pentz, M Florencia Iulita, Adriana Ducatenzeiler, et al.
Seizure|March 22, 2025
Biallelic SCN1A variants with divergent epilepsy phenotypesRowan Pentz, Rebecca Hough, Chumei Li, et al.
Journal of Neurochemistry|August 3, 2022
Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesisChiara Orciani, Hélène Hall, Rowan Pentz, et al.
Neurobiology of Disease|November 1, 2020
A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathologyRowan Pentz, M Florencia Iulita, Maya Mikutra-Cencora, et al.
Neuropharmacology|April 24, 2016
Ketamine modulates hippocampal neurogenesis and pro-inflammatory cytokines but not stressor induced neurochemical changesMelanie Clarke, Sara Razmjou, Natalie Prowse, et al.
Neuropsychiatric Disease and Treatment|September 24, 2016
The interactive effects of ketamine and magnesium upon depressive-like pathologySara Razmjou, Darcy Litteljohn, Chris Rudyk, et al.
Pageof 2